product Image
[SRH] Multiplex Real-Time PCR Kit (for Probe) (Real-Time PCR & qRT-PCR)
Model Name
-
Series
Research Reagents (PCR)
Data
메뉴얼-솔젠트-SRH22-M25h_Solg™_2X_Multiplex_Real-Time_PCR_Smart_mix_(for_Probe)
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125183
Product Name
[SRH] Multiplex Real-Time PCR Kit (for Probe) (Real-Time PCR & qRT-PCR)
Model Name
-
Size
-
Weight
-
Product Details

[SRH] Multiplex Real-Time PCR Kit (for Probe)

Probe-based detection Accurate & Ultra-high specific detection using hot start Taq


Solg™ 2X Multiplex Real-Time PCR Smart mix provides optimized system in pre-mixture for accurate and easy probe based real-time PCR. Solg™ h-Tag hot start PCR enzyme in this kit has high specificity for the target gene amplification only. And with its optimized buffer system, the kit enables to give stable and successful test results especially for multiplex Real-Time PCR.




Application

- Gene expression analysis, Quantification of target DNA using Real-Time PCR, Microbial detection, Genetic variation analysis, miRNA profiling, High Resolution Melting (HRM)





Format

FormatProduct ImageContentsStorage & Expiry Date
Standard

2X Multiplex Real-Time PCR Smart mix
(for Probe)
1 year 6 months (In case of Store at -20 ℃ ± 5 ℃)




Ordering information

FormatCat. No.ProductSizePrice (won)
Smart mixSRH22-M25hSolg ™ 2X Multiplex Real-Time PCR Smart mix (for Probe)0.5 ㎖ x 5 ea
(250 reaction)1
-
SRH41-M25hSolg ™ 2X Multiplex Real-Time PCR Smart mix (for Probe), UDG system0.5 ㎖ x 5 ea
(250 reaction)2
-

1. Reaction is calculated based on the total volume 20 μl reaction.

2. This product contains UDG system.




More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry